← Leaderboards
Dana Leifer
Columbia University Health Sciences
$482,711
Attributed
$2,288,535
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500.1K · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,288,535 · 1
By mechanism
U24$2,288,535 · 1
Top collaborators
- Edward Sander Connolly7 shared
- Randolph S Marshall7 shared
- Philip Stieg7 shared
- Matthew Fink6 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Randolph S Marshall$10,866,382
- Alfred I Neugut$17,537,198
- Edward Sander Connolly$9,326,629
- Olveen Carrasquillo$36,728,984
- Philip Stieg$589,926
Others in their field
Other Emerging Leaders on “Hospitals”
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Ted Ross · University Of Georgia$68,763,143
- Abraham Aizer Brody · New York University School Of Medicine$40,089,349
- Xinhua Li · Nano Terra, Inc.$32,991,103
- James Dale Berry · Brigham And Women'S Hospital$20,824,388
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
Research focus
HospitalsK-Series Research Career ProgramsCryptogenic StrokeHeart AtriumInnovationInstitutionAcuteCognitionEnrollmentFundingAfrican AmericanDisabilityAcademic Medical CentersDemographicsAncillary StudyCarotid StenosisAdmission ActivityCerebral HemodynamicsAdultCountyFailureFellowshipClinical TrialsLeadership
Grant awards (7)
Stroke Trials Network of Columbia and Cornell$500,083
U24 · FY2024 · NS
Stroke Trials Network of Columbia and Cornell$186,392
U24 · FY2023 · NS
Stroke Trials Network of Columbia and Cornell$311,804
U24 · FY2022 · NS
Stroke Trials Network of Columbia and Cornell$316,807
U24 · FY2021 · NS
Stroke Trials Network of Columbia and Cornell$314,615
U24 · FY2020 · NS
Stroke Trials Network of Columbia and Cornell$319,095
U24 · FY2019 · NS
Stroke Trials Network of Columbia and Cornell$339,739
U24 · FY2018 · NS